GlassScriptPhysician profile
David R Blick
NPI 1699729202
$5,901.82
in general payments reported to CMS, 2019-2025
25 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,376 · 2020: $562 · 2021: $478 · 2022: $1,284 · 2023: $626 · 2024: $425 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101 · Grant: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.49 |
| Grant | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $664.07 | 2019-2025 | General - Atherectomy, Watchman Access System |
| Janssen Pharmaceuticals, INC | $630.96 | 2019-2023 | Xarelto |
| Amgen INC. | $565.34 | 2019-2024 | Repatha |
| Biotronik INC. | $554.21 | 2019-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $447.49 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $439.70 | 2019-2024 | |
| Pfizer INC. | $436.96 | 2019-2023 | |
| Amarin Pharma, INC. | $297.04 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $268.23 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $254.44 | 2019-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $235.87 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.92 | 2019-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.87 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $161.77 | 2019-2022 | |
| Medtronic, INC. | $101.49 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $84.50 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $76.11 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $73.17 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $68.71 | 2021-2022 | |
| Philips North America LLC | $52.50 | 2022-2023 | |
| Kiniksa Pharmaceuticals, LTD. | $42.77 | 2022-2023 | Arcalyst |
| Shockwave Medical, INC | $32.88 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $20.51 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $18.31 | 2020 | |
| Penumbra, INC. | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.